AnnouncementsAmrutanjan Health Care: Board declares Interim Dividend
AnnouncementsAmrutanjan Health Care to consider interim dividend
|Company Name||Last Price||%
|Dr Reddys Labs||2726.25||-3.59||2939.80||1786.50||46,375.93|
|Dec' 13||Sep' 13||Jun' 13||Mar' 13|
|No Mutual Funds Holding the share|
Amrutanjan Heal is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 183.79 crore.The company has reported a standalone sales of Rs 40.60 crore and a Net Profit of Rs 5.08 crore for the quarter ended Dec 2013.
The company management includes S Sambhu Prasad - Chairman & Managing Director, H B N Shetty - Director, D Seetharama Rao - Director, Pasumarthi S N Murthi - Director, A Satish Kumar - Director, Marie Shiranee Pereira - Director.
It is listed on the BSE with a BSE Code of 590006 and the NSE with an NSE Code of AMRUTANJAN.
Its Registered office is at No. 103 (Old No.42-45), Luz Church Road,,Mylapore Chennai (Madras),Tamil Nadu - 600004.
Their Registrars are Cameo Corporate Services Ltd.